Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like Oligodendrocytes identified as key source of amyloid beta in Alzheimer’s disease July 23, 2024 Showcasing neuroprotective effects of citicoline at NUTRITION 2024 June 28, 2024 Large language models help predict epileptogenic zones for surgery May 12, 2025